325 related articles for article (PubMed ID: 11733975)
21. Aspirin and epithelial ovarian cancer.
Akhmedkhanov A; Toniolo P; Zeleniuch-Jacquotte A; Kato I; Koenig KL; Shore RE
Prev Med; 2001 Dec; 33(6):682-7. PubMed ID: 11716667
[TBL] [Abstract][Full Text] [Related]
22. Breastfeeding and risk of epithelial ovarian cancer.
Jordan SJ; Siskind V; C Green A; Whiteman DC; Webb PM
Cancer Causes Control; 2010 Jan; 21(1):109-16. PubMed ID: 19779839
[TBL] [Abstract][Full Text] [Related]
23. Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies.
Riman T; Nilsson S; Persson IR
Acta Obstet Gynecol Scand; 2004 Sep; 83(9):783-95. PubMed ID: 15315588
[TBL] [Abstract][Full Text] [Related]
24. Association of estrogen and progestin potency of oral contraceptives with ovarian carcinoma risk.
Lurie G; Thompson P; McDuffie KE; Carney ME; Terada KY; Goodman MT
Obstet Gynecol; 2007 Mar; 109(3):597-607. PubMed ID: 17329510
[TBL] [Abstract][Full Text] [Related]
25. Timing of pregnancy and the risk of epithelial ovarian cancer.
Whiteman DC; Siskind V; Purdie DM; Green AC
Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):42-6. PubMed ID: 12540502
[TBL] [Abstract][Full Text] [Related]
26. Lifetime ovulatory cycles and ovarian cancer risk in 2 Italian case-control studies.
Pelucchi C; Galeone C; Talamini R; Bosetti C; Montella M; Negri E; Franceschi S; La Vecchia C
Am J Obstet Gynecol; 2007 Jan; 196(1):83.e1-7. PubMed ID: 17240246
[TBL] [Abstract][Full Text] [Related]
27. Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer.
Glud E; Kjaer SK; Thomsen BL; Høgdall C; Christensen L; Høgdall E; Bock JE; Blaakaer J
Arch Intern Med; 2004 Nov; 164(20):2253-9. PubMed ID: 15534163
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
[TBL] [Abstract][Full Text] [Related]
29. Clinical factors and biomarkers in ovarian tumors development.
Vrabie CD; Petrescu A; Waller M; Dina I
Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
[TBL] [Abstract][Full Text] [Related]
30. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.
Shantakumar S; Terry MB; Paykin A; Teitelbaum SL; Britton JA; Moorman PG; Kritchevsky SB; Neugut AI; Gammon MD
Am J Epidemiol; 2007 May; 165(10):1187-98. PubMed ID: 17337757
[TBL] [Abstract][Full Text] [Related]
31. Progesterone receptor promoter +331A polymorphism is associated with a reduced risk of endometrioid and clear cell ovarian cancers.
Berchuck A; Schildkraut JM; Wenham RM; Calingaert B; Ali S; Henriott A; Halabi S; Rodriguez GC; Gertig D; Purdie DM; Kelemen L; Spurdle AB; Marks J; Chenevix-Trench G
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2141-7. PubMed ID: 15598772
[TBL] [Abstract][Full Text] [Related]
32. Endometrioid and clear cell ovarian cancers: a comparative analysis of risk factors.
Nagle CM; Olsen CM; Webb PM; Jordan SJ; Whiteman DC; Green AC; ;
Eur J Cancer; 2008 Nov; 44(16):2477-84. PubMed ID: 18707869
[TBL] [Abstract][Full Text] [Related]
33. The epidemiology of ovarian granulosa cell tumors: a case-control study.
Boyce EA; Costaggini I; Vitonis A; Feltmate C; Muto M; Berkowitz R; Cramer D; Horowitz NS
Gynecol Oncol; 2009 Nov; 115(2):221-5. PubMed ID: 19664811
[TBL] [Abstract][Full Text] [Related]
34. Estrogen replacement therapy and risk of epithelial ovarian cancer.
Risch HA
Gynecol Oncol; 1996 Nov; 63(2):254-7. PubMed ID: 8910636
[TBL] [Abstract][Full Text] [Related]
35. Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer.
Wenham RM; Schildkraut JM; McLean K; Calingaert B; Bentley RC; Marks J; Berchuck A
Clin Cancer Res; 2003 Oct; 9(12):4396-403. PubMed ID: 14555511
[TBL] [Abstract][Full Text] [Related]
36. Menopausal hormones and risk of ovarian cancer.
Moorman PG; Schildkraut JM; Calingaert B; Halabi S; Berchuck A
Am J Obstet Gynecol; 2005 Jul; 193(1):76-82. PubMed ID: 16021062
[TBL] [Abstract][Full Text] [Related]
37. Body weight and body mass index and ovarian cancer risk: a case-control study in China.
Zhang M; Xie X; Holman CD
Gynecol Oncol; 2005 Aug; 98(2):228-34. PubMed ID: 15979697
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for breast cancer in Turkish women: a hospital-based case-control study.
Beji NK; Reis N
Eur J Cancer Care (Engl); 2007 Mar; 16(2):178-84. PubMed ID: 17371428
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for pituitary tumors: a case-control study.
Schoemaker MJ; Swerdlow AJ
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1492-500. PubMed ID: 19423526
[TBL] [Abstract][Full Text] [Related]
40. Risk of brain tumors associated with exposure to exogenous female sex hormones.
Wigertz A; Lönn S; Mathiesen T; Ahlbom A; Hall P; Feychting M;
Am J Epidemiol; 2006 Oct; 164(7):629-36. PubMed ID: 16835295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
